Search

Jingxuan Liu

from West Roxbury, MA
Age ~48

Jingxuan Liu Phones & Addresses

  • 6 Plover St, West Roxbury, MA 02132
  • Roslindale, MA
  • Auburndale, MA
  • Havertown, PA
  • Drexel Hill, PA
  • Wayne, PA
  • East Haven, CT
  • Havertown, PA

Work

Company: Dana farber cancer institute Jan 2013 Position: Research fellow

Education

School / High School: University of Pennsylvania, Perelman School of Medicine- Philadelphia, PA 2004 Specialities: Ph.D. in Cell and Molecular Biology

Skills

Cell and molecular biology: Tissue culture • Lentivirus generation • siRNA-mediated gene knockdown • transfection • stable cell line generation • various immuno-stainings • Chromatin- IP • FACS • luciferase reporter assays • cell proliferation MTT assay • cloning • DNA/RNA preparation Gateway plasmid clon... • PCR • Q-PCR • site-directed mutagenesis • mRNA microarray • in situ hybridization • Confocal Microscopy • etc. Protein biochemistry: small and lar... • yeast and mammalian cell hosts • protein chromatographic purifications • in vitro binding • IP • Western blotting • ELISA • GTPase enzymatic assays • etc. Small animal models: basic handling... • metabolic assays (glucose tolerance) • organ isolation and culture (islets) • embryonic tissue dissection • fixation and sectioning. Bioinformatics ... • DNA sequences • microscopic data • and protein structures.

Professional Records

Medicine Doctors

Jingxuan Liu Photo 1

Jingxuan Xuan Liu

View page
Specialties:
Pathology
Anatomic Pathology & Clinical Pathology
Education:
Peking Union Medical University (1991)

Resumes

Resumes

Jingxuan Liu Photo 2

Senior Control And Diagnostic Research Engineer

View page
Location:
2391 Creek Bank Dr, Columbus, IN 47201
Industry:
Automotive
Work:
Cummins Inc.
Senior Control and Diagnostic Research Engineer

Automotive Research Center Sep 2014 - May 2015
Graduate Student Research Assistant

Eaton May 2014 - Aug 2014
Corporate Research and Technology Intern

Autonomous Aerospace Systems Lab Univeristy of Michigan Ann Arbor Apr 2013 - Dec 2013
Undergraduate Research Assistant

Applied Dynamics International May 2013 - Aug 2013
Intern Application Engineer
Education:
University of Michigan 2016 - 2017
University of Michigan 2014 - 2016
Shanghai Jiao Tong University 2010 - 2014
Bachelors, Mechanical Engineering
University of Michigan 2012 - 2014
Bachelors, Engineering, Aerospace Engineering
Shanghai Jincai High School
Skills:
Solidworks
Simulink
Labview
Latex
Computer Aided Design
Matlab
Nx
Cad
Avl
Nx Unigraphics
Testing
Finite Element Analysis
Ansa
Dynamics and Control and Cad Design
Ansys
Tornado
Catia
20Sim
Interests:
Badminton
Table Tennisphotography
Table Tennis Photography
Running
Swimming
Languages:
Mandarin
English
Certifications:
Improving Deep Neural Networks: Hyperparameter Tuning, Regularization and Optimization
Neural Networks and Deep Learning
Structuring Machine Learning Projects
Convolutional Neural Networks
Sequence Models
Deep Learning Specialization
Self-Driving Car Engineer Nanodegree
Jingxuan Liu Photo 3

Senior Scientist

View page
Location:
Boston, MA
Industry:
Biotechnology
Work:
Alnylam Pharmaceuticals
Senior Scientist

Alnylam Pharmaceuticals Apr 2014 - Jul 2017
Scientist

Dana-Farber Cancer Institute Jan 2013 - Apr 2014
Research Fellow

The Children's Hospital of Philadelphia Apr 2009 - Dec 2011
Postdoctoral Fellow

University of Pennsylvania Sep 2004 - Dec 2008
Graduate Student
Education:
University of Pennsylvania 2004 - 2008
Doctorates, Doctor of Philosophy, Molecular Biology, Philosophy
Xiamen University 1995 - 1999
Bachelors, Bachelor of Science, Biology
Skills:
Molecular Biology
Biochemistry
Cell Culture
Confocal Microscopy
Protein Chemistry
Cell Biology
Immunoprecipitation
Cell
Genetics
Western Blotting
Animal Models
Protein Expression
Protein Purification
Molecular Cloning
Transfection
Chip
Cancer Genomics
Lentivirus
Assay Development
Fluorescence Microscopy
Life Sciences
Biotechnology
Drug Discovery
Polymerase Chain Reaction
Elisa
Real Time Polymerase Chain Reaction
In Vitro
Ind Pharmacology
Reverse Transcription Polymerase Chain Reaction
In Vivo
Pharmaceutical Industry
Ind
Rnai
Pharmacology
Translational Research
Sds Page
Purification
Reverse Transcription
English
Translational Medicine
Biomarker Discovery
Cro Management
Disease Model
Biomarkers
Cell Based Assays
Languages:
Mandarin
English
Jingxuan Liu Photo 4

Jingxuan Liu

View page
Jingxuan Liu Photo 5

Jingxuan Liu

View page
Skills:
Product Management
Jingxuan Liu Photo 6

Jingxuan Liu Newton, MA

View page
Work:
Dana Farber Cancer Institute

Jan 2013 to 2000
Research Fellow

Children's Hospital of Philadelphia
Philadelphia, PA
Apr 2009 to Dec 2011
Postdoctoral Fellow

University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
Sep 2004 to Dec 2008
Graduate Student

Dana-Farber Cancer Institute, Harvard Medical School
Boston, MA
May 2002 to Jul 2004
Research Assistant

Institute of Biophysics
Xiamen, CN
Jan 1999 to Jul 1999
Research Assistant

Education:
University of Pennsylvania, Perelman School of Medicine
Philadelphia, PA
2004 to 2008
Ph.D. in Cell and Molecular Biology

Xiamen University
Xiamen, CN
1995 to 1999
B.S. in Cell Biology

Skills:
Cell and molecular biology: Tissue culture, Lentivirus generation, siRNA-mediated gene knockdown, transfection, stable cell line generation, various immuno-stainings, Chromatin- IP, FACS, luciferase reporter assays, cell proliferation MTT assay, cloning, DNA/RNA preparation Gateway plasmid cloning, PCR, Q-PCR, site-directed mutagenesis, mRNA microarray, in situ hybridization, Confocal Microscopy, etc. Protein biochemistry: small and large scale protein over-expression using E. coli, yeast and mammalian cell hosts, protein chromatographic purifications, in vitro binding, IP, Western blotting, ELISA, GTPase enzymatic assays, etc. Small animal models: basic handling skills, metabolic assays (glucose tolerance), organ isolation and culture (islets), embryonic tissue dissection, fixation and sectioning. Bioinformatics processing and analysis: ChIP-seq and expression array data analysis, DNA sequences, microscopic data, and protein structures.

Publications

Us Patents

Xanthine Dehydrogenase (Xdh) Irna Compositions And Methods Of Use Thereof

View page
US Patent:
20220411801, Dec 29, 2022
Filed:
Mar 1, 2022
Appl. No.:
17/683423
Inventors:
- Cambridge MA, US
Jingxuan Liu - West Roxbury MA, US
Mark K. Schlegel - Boston MA, US
Adam Castoreno - Framingham MA, US
Anna Borodovsky - Melrose MA, US
International Classification:
C12N 15/113
A61K 47/54
A61K 31/713
Abstract:
The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the xanthine dehydrogenase (XDH) gene. The invention also relates to methods of using such RNAi agents to inhibit expression of an XDH gene and to methods of treating or preventing an XDH-associated disease in a subject.

Methods For Treating Or Preventing Contact-Activation Pathway-Associated Diseases Using Irna Compositions Targeting Factor Xii (Hageman Factor) (F12)

View page
US Patent:
20220267767, Aug 25, 2022
Filed:
Sep 28, 2021
Appl. No.:
17/487019
Inventors:
- Cambridge MA, US
Jingxuan Liu - West Roxbury MA, US
International Classification:
C12N 15/113
A61P 9/00
Abstract:
The present invention relates to methods of use of RNAi agents, e.g., double stranded RNAi agents, targeting a Factor XII (Hageman Factor (F12) gene, for treating subjects having a contact activation pathway-associated disease, such as a thrombophilia or hereditary angioedema (HAE), methods for preventing at least one symptom in a subject having a contact activation pathway-associated disease, such as a thrombus formation or an angioedema attack, and RNAi agents targeting an F12 gene, for use in the methods of the invention.

Factor Xii (Hageman Factor) (F12), Kallikrein B, Plasma (Fletcher Factor) 1 (Klkb1), And Kininogen 1 (Kng1) Irna Compositions And Methods Of Use Thereof

View page
US Patent:
20210246447, Aug 12, 2021
Filed:
Dec 15, 2020
Appl. No.:
17/121858
Inventors:
- Cambridge MA, US
Gregory Hinkle - Cambridge MA, US
Martin A. Maier - Belmont MA, US
James Butler - Lynnfield MA, US
Jingxuan Liu - West Roxbury MA, US
International Classification:
C12N 15/113
A61K 31/713
A61K 45/06
A61K 47/54
C12Q 1/6883
Abstract:
The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting the Kallikrein B, Plasma (Fletcher Factor) 1 (KLKB1) gene, the Factor XII (Hageman Factor (F12) gene, or the Kininogen 1 (KNG1) gene, and methods of using such RNAi agents to inhibit expression of a KLKB1 gene, an F12 gene, and/or a KNG1 gene, and methods of treating subjects having an hereditary angioedema (HAE) and/or a contact activation pathway-associated disorder.

Methods For Treating Or Preventing Contact-Activation Pathway-Associated Diseases Using Irna Compositions Targeting Factor Xii (Hageman Factor) (F12)

View page
US Patent:
20200208150, Jul 2, 2020
Filed:
Jul 6, 2018
Appl. No.:
16/621754
Inventors:
- Cambridge MA, US
Jingxuan Liu - West Roxbury MA, US
International Classification:
C12N 15/113
A61P 9/00
Abstract:
The present invention relates to methods of use of RNAi agents, e.g., double stranded RNAi agents, targeting a Factor XII (Hageman Factor (F12) gene, for treating subjects having a contact activation pathway-associated disease, such as a thrombophilia or hereditary angioedema (HAE), methods for preventing at least one symptom in a subject having a contact activation pathway-associated disease, such as a thrombus formation or an angioedema attack, and RNAi agents targeting an F12 gene, for use in the methods of the invention.

Factor Xii (Hageman Factor) (F12), Kallikrein B, Plasma (Fletcher Factor) 1 (Klkb1), And Kininogen 1 (Kng1) Irna Compositions And Methods Of Use Thereof

View page
US Patent:
20180100150, Apr 12, 2018
Filed:
Nov 1, 2017
Appl. No.:
15/800517
Inventors:
- Cambridge MA, US
Gregory Hinkle - Cambridge MA, US
Martin Maier - Belmont MA, US
James Butler - Lynnfield MA, US
Jingxuan Liu - West Roxbury MA, US
International Classification:
C12N 15/113
C12Q 1/6883
Abstract:
The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting the Kallikrein B, Plasma (Fletcher Factor) 1 (KLKB1) gene, the Factor XII (Hageman Factor (F12) gene, or the Kininogen 1 (KNG1) gene, and methods of using such RNAi agents to inhibit expression of a KLKB1 gene, an F12 gene, and/or a KNG1 gene, and methods of treating subjects having an hereditary angioedema (HAE) and/or a contact activation pathway-associated disorder.
Jingxuan Liu from West Roxbury, MA, age ~48 Get Report